Molina Healthcare Inc (MOH) : Traders are bullish on Molina Healthcare Inc (MOH) as it has outperformed the S&P 500 by a wide margin of 10.3% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 7.18%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 7.11% in the last 1 week, and is up 14.01% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 10.36% and the 50-Day Moving Average is 12.75%. Molina Healthcare, Inc. is up 9.76% in the last 3-month period. Year-to-Date the stock performance stands at -5.52%.
Molina Healthcare Inc (NYSE:MOH): On Fridays trading session , Opening price of the stock was $56.76 with an intraday high of $57.29. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $56.07. However, the stock managed to close at $56.81, a loss of 0.70% for the day. On the previous day, the stock had closed at $57.21. The total traded volume of the day was 1,113,140 shares.
Molina Healthcare, Inc. provides health care to those receiving Government assistance. The Company offers Medicaid-related solutions for low-income families and individuals, and assists state agencies in their administration of the Medicaid program. The Company operates through two segments: Health Plans segment and Molina Medicaid Solutions segment. The Companys Health Plans segment consists of health plans in around 11 states, and includes its direct delivery business. The Companys direct delivery business consists primarily of the management of a hospital in southern California, and the operation of primary care clinics in several states in which the Company operates. The Companys Molina Medicaid Solutions segment provides business processing and information technology development, and administrative services to Medicaid agencies in Idaho, Louisiana, Maine, New Jersey, West Virginia, and the United States Virgin Islands, and drug rebate administration services in Florida.